These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19816987)

  • 1. Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias.
    Abuissa H; O'Keefe JH; Bybee KA
    Clin Cardiol; 2009 Oct; 32(10):549-52. PubMed ID: 19816987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation.
    Abuissa H; O'Keefe JH; Bybee KA
    Clin Cardiol; 2009 Oct; 32(10):544-8. PubMed ID: 19911349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-arrhythmic effects of statins: a hypothesis remains to be tested.
    Guo HM
    Heart Rhythm; 2008 Apr; 5(4):511-2. PubMed ID: 18362017
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arrhythmias in cardiomyopathies].
    Kaneko Y; Kurabayashi M
    Nihon Rinsho; 2002 Jul; 60(7):1434-9. PubMed ID: 12136626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Change in therapy of cardiac arrhythmias. Current studies--initial results].
    Meinertz T
    Med Klin (Munich); 1997 Apr; 92(4):211-4. PubMed ID: 9221303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death prevention: antiarrhythmic drugs and the implantable cardioverter-defibrillator.
    Domanski MJ
    J Interv Cardiol; 1995 Feb; 8(1):9-15. PubMed ID: 10155222
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
    Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
    Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
    Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
    Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy.
    Goldberger JJ; Subacius H; Schaechter A; Howard A; Berger R; Shalaby A; Levine J; Kadish AH;
    J Am Coll Cardiol; 2006 Sep; 48(6):1228-33. PubMed ID: 16979011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
    Stevenson WG; Ridker PM
    JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins, ventricular arrhythmias and heart rate variability in patients with implantable cardioverter defibrillators and coronary heart disease.
    Riahi S; Schmidt EB; Christensen JH; Heath F; Pedersen AK; Nielsen JC; Mølgaard H; Toft E
    Cardiology; 2005; 104(4):210-4. PubMed ID: 16155396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies for use of the implantable cardioverter defibrillator: the impact of current trials.
    Estes NA
    Pacing Clin Electrophysiol; 1996 Jul; 19(7):1011-5. PubMed ID: 8823825
    [No Abstract]   [Full Text] [Related]  

  • 17. Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect?
    Beri A; Contractor T; Khasnis A; Thakur R
    Am J Cardiovasc Drugs; 2010; 10(3):155-64. PubMed ID: 20524717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
    Cooley R; Akhtar M; Sra J
    Curr Cardiol Rep; 1999 Nov; 1(4):268-73. PubMed ID: 10980853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.